The Pennsylvania Horse Breeders Association (PHBA) today announced a $150,000 grant to the Equine Pharmacology Laboratory at the new Bolton Center of the University of Pennsylvania School of Veterinary Medicine (Penn Vet), to support continued revolutionary research in equine biomarkers.
PHBA’s new round of funding – which will expand on the cutting-edge research PHBA helped fund in 2018 – will support three key research initiatives focused on improving the health and safety of equestrian athletes and promote racing integrity. An area of research that seeks to identify novel mRNA biomarkers that can help proactively predict whether horses are at risk of injury, even for wounds that are difficult or impossible to detect with these methods. usually, common, normal. Eventually, the researchers hope to develop a rapid side-by-side blood test that can be performed before a race, helping race officials accurately spot horses that may be at risk. high.
This grant will also support Penn Vet’s sample collection to further develop the equine BioPassport through the expansion of the Equine Pharmacology Lab BioBank. Samples from BioBank were analyzed to determine baseline levels of blood-based biomarkers found in seahorses. Once established, these baseline levels can be used to determine whether blood samples taken from horses before or after a race are any different from the initial sign of illness or injury. or prohibited substances.
“PHBA is very proud to continue our partnership with Penn Vet by providing an additional $150,000 to fund this incredibly important and timely research program,” said Deanna Manfredi, PhD, member of the Board of Trustees. Pennsylvania Horse Breeders Association said. “This research program has the potential to have a very positive impact on the sport we all love and ensure its continued success through advances in incident prevention, health promotion of horses and enhance the integrity of the sport.”
“Studies are underway to develop the equine BioPassport using a variety of biomarkers,” said Dr. Mary Robinson, Director of the Equine Pharmacology Laboratory at the New Bolton Center. “For example, we currently have potential protein and mRNA biomarkers of extracorporeal shock wave therapy being studied using our Equine Biobank samples. This work would not be possible. This would not have been possible without the support of the Pennsylvania Horse Breeders Association, who provided funding to expand and maintain the Equine Biobank, and the support of the Pennsylvania Equestrian Commission for the room. my experiment.”
“I am proud to see the ongoing partnership between the Pennsylvania Horse Breeders Association and the New Bolton Center. This partnership promotes integrity and safety in the horse racing industry,” said State Representative Christina Sappey, representative for the 158th State Sector, said. “The cutting-edge research developed by Penn Vet’s New Bolton Center is vitally important to protecting equestrian athletes, and PHBA’s generous support makes this possible. We’re lucky. having both of these organizations benefit all Pennsylvanians here for the 158th!”
In addition to the support of the Pennsylvania Horse Breeders Association, Penn Vet’s New Bolton Center is also seeking additional funding to further expand and accelerate this research program. Individuals or organizations interested in supporting the program through financial donations are encouraged to contact Margaret Leardi, Director of Development for the New Bolton Center, at [email protected].
Industry News – To support purebred industry organizations, BloodHorse publishes industry-related newsletters. Unedited releases by Blood-Horse. If you have any questions please contact the organization that produced the newsletter as directed in the newsletter.
